title: [Comparative economic and clinical effectiveness of setegis and camiren in therapy of chronic prostatitis].
abstract: The drugs setegis 2 mg, camiren 2 mg, were used in the investigation designed to study economic and clinical effectiveness of employment of alpha-blockers for treating chronic prostatitis, with the expediency of the above therapeutic modality having been corraborated by the findings secured. Objective control of the treatments administered necessitates studying the time-related changes in indices for the amount of the residual urine and volume of the prostate. Economic expediency has been shown of use of camiren 2 mg, an alpha-blocker, of the KRKA firm, which fact was validated by a lower cost of the drug at the retail market of Ukraine compared to setegis 2 mg.
authors.forename: B T
authors.initials: BT
authors.lastname: Glukhen'kiĭ
authors.forename: A V
authors.initials: AV
authors.lastname: Martynenko
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000191:economics* / Q000627:therapeutic use*; D000328:Adult; D002908:Chronic Disease; D003362:Cost-Benefit Analysis; D004231:Diuresis / Q000187:drug effects; D016527:Drug Costs; D006801:Humans; D008297:Male; D008875:Middle Aged; D011472:Prostatitis / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D000317:Adrenergic alpha-Antagonists